Stock Pick : Altera, Agilent -> Which one is the best?

Altera business provides high profit margin with less capital required compare to Agilent.

Altera : Every USD1,000 invested into Altera Share, it generates  USD360 return p.a
Agilent: Every USD1,000 invested into Agilent Share, it generates USD230 return p.a

Conclusion:-
Altera is a winner in term of profitablity (50% higher than Agilent)

Altera Stock outperform Agilent share by 100% over the 5 years...............

Altera
Business Overview :-
Altera Corporation is a semiconductor company. Altera designs, manufactures and markets programmable logic devices (PLDs), HardCopy application-specific integrated circuits (ASICs), intellectual property (IP) cores and development software. The Company’s PLDs consist of field-programmable gate arrays (FPGAs) and complex programmable logic devices (CPLDs), which are semiconductor integrated circuits, or chips, that its customers program to perform logic functions in their electronic systems. Its HardCopy ASICs enables its customer to transition designs from FPGAs to non-programmable implementations. Altera’s IP cores are pre-defined design building blocks that can be licensed by customers to add functions to their PLD designs. The development software, which operates on personal computers and engineering workstations, is used by customers to develop, compile and verify their designs, and then program their designs into its PLDs.

Agilent
Business Overview:-
Agilent Technologies, Inc. (Agilent) is a measurement company providing bio-analytical and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries. During the fiscal year ended October 31, 2010 (fiscal 2010), the Company operated in three segments: electronic measurement business, the chemical analysis business and the life sciences business. Its electronic measurement business addresses the communications, electronics and other industries. Its chemical analysis business focuses on the petrochemical, environmental, forensics and food safety industries. In February 2011, the Company acquired Lab901. In March 2011, the Company acquired BIOCIUS Life Sciences, Inc.